IL127703A0 - Polynucleotide vaccine formula particularly for treating bovine respiratory disease - Google Patents

Polynucleotide vaccine formula particularly for treating bovine respiratory disease

Info

Publication number: IL127703A0
Authority: IL; Israel
Prior art keywords: respiratory disease; bovine respiratory; polynucleotide vaccine; treating bovine; vaccine formula
Prior art date: 1996-07-19

Application number

IL12770397A

Other languages

English (en)

Original Assignee

Merial Sas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-19

Filing date

1997-07-16

Publication date

1999-10-28

1997-07-16 Application filed by Merial Sas filed Critical Merial Sas

1999-10-28 Publication of IL127703A0 publication Critical patent/IL127703A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/813—Viral vaccine for bovine species, e.g. cattle

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biotechnology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL12770397A 1996-07-19 1997-07-16 Polynucleotide vaccine formula particularly for treating bovine respiratory disease IL127703A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9609403A FR2751229B1 (fr)	1996-07-19	1996-07-19	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
PCT/FR1997/001325 WO1998003200A2 (fr)	1996-07-19	1997-07-16	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins

Publications (1)

Publication Number	Publication Date
IL127703A0 true IL127703A0 (en)	1999-10-28

Family

ID=9494497

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12770397A IL127703A0 (en)	1996-07-19	1997-07-16	Polynucleotide vaccine formula particularly for treating bovine respiratory disease
IL127703A IL127703A (en)	1996-07-19	1998-12-23	Polynucleotide vaccine formula particularly for treating bovine respiratory disease

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL127703A IL127703A (en)	1996-07-19	1998-12-23	Polynucleotide vaccine formula particularly for treating bovine respiratory disease

Country Status (28)

Country	Link
US (2)	US6376473B1 (xx)
EP (2)	EP0912194B1 (xx)
JP (1)	JP2000516200A (xx)
AP (1)	AP9701044A0 (xx)
AR (1)	AR007862A1 (xx)
AT (2)	ATE253376T1 (xx)
AU (1)	AU734442B2 (xx)
BR (1)	BR9710506A (xx)
CA (1)	CA2260855C (xx)
CO (1)	CO4700306A1 (xx)
CZ (2)	CZ298898B6 (xx)
DE (2)	DE69725988T2 (xx)
DK (2)	DK1382348T3 (xx)
ES (2)	ES2210548T3 (xx)
FR (1)	FR2751229B1 (xx)
HR (1)	HRP970383A2 (xx)
HU (2)	HU225169B1 (xx)
ID (1)	ID19513A (xx)
IL (2)	IL127703A0 (xx)
MA (1)	MA24269A1 (xx)
NZ (4)	NZ517686A (xx)
PE (1)	PE84699A1 (xx)
PL (1)	PL190122B1 (xx)
PT (1)	PT912194E (xx)
RU (1)	RU2305560C2 (xx)
UA (1)	UA70914C2 (xx)
WO (1)	WO1998003200A2 (xx)
ZA (1)	ZA976283B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
US7078388B2 (en)	2000-01-21	2006-07-18	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US20040002472A1 (en) *	2000-01-21	2004-01-01	Audonnet Jean-Christophe Francis	Vaccination or immunization using a prime-boost regimen
FR2804028B1 (fr) *	2000-01-21	2004-06-04	Merial Sas	Vaccins adn ameliores pour animaux de rente
US6852705B2 (en) *	2000-01-21	2005-02-08	Merial	DNA vaccines for farm animals, in particular bovines and porcines
US7906311B2 (en)	2002-03-20	2011-03-15	Merial Limited	Cotton rat lung cells for virus culture
EP2390352A1 (en)	2003-03-18	2011-11-30	Quantum Genetics Ireland Limited	Systems and methods for improving protein and milk production of dairy herds
US7468273B2 (en)	2003-05-01	2008-12-23	Meial Limited	Canine GHRH gene, polypeptides and methods of use
EP1689858B1 (en)	2003-11-13	2013-05-15	University Of Georgia Research Foundation, Inc.	Methods of characterizing infectious bursal disease virus
EP1718770B1 (en)	2004-02-19	2011-05-25	The Governors of the University of Alberta	Leptin promoter polymorphisms and uses thereof
SI1881845T1 (sl)	2005-04-25	2010-06-30	Merial Ltd	Cepiva proti virusu Nipah
US20080241184A1 (en)	2005-08-25	2008-10-02	Jules Maarten Minke	Canine influenza vaccines
EP3147296A1 (en)	2005-11-14	2017-03-29	Merial, Inc.	Gene therapy for renal failure
US7771995B2 (en)	2005-11-14	2010-08-10	Merial Limited	Plasmid encoding human BMP-7
US7862821B2 (en)	2006-06-01	2011-01-04	Merial Limited	Recombinant vaccine against bluetongue virus
HRP20130643T1 (hr)	2007-05-02	2013-08-31	Merial Limited	Dnk-plazmidi koji imaju poboljšanu ekspresiju i stabilnost
US20080274137A1 (en) *	2007-05-02	2008-11-06	Jean Christophe Francis Audonnet	DNA plasmids having improved expression and stability
EP3168307B1 (en)	2008-11-28	2020-07-15	Boehringer Ingelheim Animal Health USA Inc.	Recombinant avian influenza vaccine and uses thereof
KR101715418B1 (ko)	2009-04-03	2017-03-10	메리얼 인코포레이티드	뉴캐슬 질환 바이러스-벡터를 이용한 조류 백신
KR20120101572A (ko)	2009-12-28	2012-09-13	메리얼 리미티드	재조합 ｎｄｖ 항원 및 이의 용도
AU2011207626B2 (en)	2010-01-19	2015-06-18	President And Fellows Of Harvard College	Engineered opsonin for pathogen detection and treatment
US20130197612A1 (en)	2010-02-26	2013-08-01	Jack W. Lasersohn	Electromagnetic Radiation Therapy
AU2011224188B2 (en)	2010-03-12	2015-01-22	Boehringer Ingelheim Animal Health USA Inc.	Bluetongue virus recombinant vaccines and uses thereof
WO2012030720A1 (en)	2010-08-31	2012-03-08	Merial Limited	Newcastle disease virus vectored herpesvirus vaccines
AR084358A1 (es) *	2010-12-27	2013-05-08	Lilly Co Eli	Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc))
WO2012090073A2 (en)	2010-12-30	2012-07-05	The Netherlands Cancer Institute	Methods and compositions for predicting chemotherapy sensitivity
AU2012240246A1 (en)	2011-04-04	2013-05-09	Netherlands Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
AU2012240240A1 (en)	2011-04-04	2013-05-09	Netherlands Cancer Institute	Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors
AU2012245395A1 (en)	2011-04-20	2013-11-14	Merial, Inc.	Adjuvanted rabies vaccine with improved viscosity profile
AP2013007180A0 (en)	2011-04-25	2013-10-31	Advanced Bioscience Lab Inc	Truncated HIV envelope proteins (ENV), methods andcompositions related thereto
MX361804B (es)	2011-05-27	2018-12-17	Boehringer Ingelheim Animal Health Usa Inc	Vacunas genéticas contra el virus hendra y el virus nipah.
CA2837375C (en)	2011-06-01	2019-07-16	Merial Limited	Needle-free administration of prrsv vaccines
US9593160B2 (en)	2011-07-18	2017-03-14	President And Fellows Of Harvard College	Engineered microbe-targeting molecules and uses thereof
ES2626297T3 (es)	2011-08-12	2017-07-24	Merial, Inc.	Preservación asistida por vacío de productos biológicos, en particular de vacunas
WO2013093629A2 (en)	2011-12-20	2013-06-27	Netherlands Cancer Institute	Modular vaccines, methods and compositions related thereto
WO2013106558A1 (en)	2012-01-10	2013-07-18	Merial Limited	Lipid based adjuvants for dna - plasmid vaccines
KR102087458B1 (ko)	2012-02-14	2020-03-10	뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드	로타바이러스 아단위 백신 및 그의 제조 방법 및 용도
CN104203271B (zh)	2012-02-14	2017-08-25	梅里亚股份有限公司	表达狂犬病病毒和ox40蛋白的重组痘病毒载体及从其制造的疫苗
WO2013138776A1 (en)	2012-03-16	2013-09-19	Merial Limited	Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g
CN104582724A (zh)	2012-06-13	2015-04-29	梅里亚有限公司	重配btv和ahsv疫苗
EA031453B1 (ru)	2012-08-01	2019-01-31	Бавариан Нордик А/С	Рекомбинантный модифицированный вирус осповакцины анкара (mva) и его применение
HK1216006A1 (zh)	2013-03-12	2016-10-07	Boehringer Ingelheim Animal Health USA Inc.	反向遺傳學施馬倫貝格病毒疫苗組合物，和其使用方法
WO2014144325A1 (en)	2013-03-15	2014-09-18	President And Fellows Of Harvard College	Methods and compositions for improving detection and/or capture of a target entity
US9988617B2 (en)	2013-05-21	2018-06-05	President And Fellows Of Harvard College	Engineered heme-binding compositions and uses thereof
WO2015095604A2 (en)	2013-12-18	2015-06-25	President And Fellows Of Harvard College	Methods and assays relating to circulating tumor cells
EP3215188A1 (en)	2014-11-03	2017-09-13	Merial, Inc.	Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
NZ738957A (en)	2015-06-23	2019-09-27	Boehringer Ingelheim Animal Health Usa Inc	Prrsv minor protein-containing recombinant viral vectors and methods of making and use thereof
EP3763378A1 (en)	2015-08-06	2021-01-13	President and Fellows of Harvard College	Improved microbe-binding molecules and uses thereof
CA2996143A1 (en)	2015-08-20	2017-02-23	Merial, Inc.	Fcv recombinant vaccines and uses thereof
RU2710854C1 (ru)	2015-09-29	2020-01-14	Мериал, Инк.	Вакцины на основе вирусоподобных частиц (vlp) собачьего парвовируса (cpv) и их применение
ES2899230T3 (es)	2015-11-23	2022-03-10	Boehringer Ingelheim Animal Health Usa Inc	Proteínas de fusión de FMDV y E2 y usos de las mismas
TWI760322B (zh)	2016-01-29	2022-04-11	美商百靈佳殷格翰動物保健美國有限公司	重組腺病毒載體裝載之fmdv疫苗及其用途
CN109021081B (zh) *	2018-08-10	2019-06-04	山东大学	一种牛病毒性腹泻病毒样颗粒及其构建方法与应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5169628A (en) *	1988-04-22	1992-12-08	The Upjohn Company	Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
HUT67362A (en) *	1990-07-24	1995-03-28	Uab Research Foundation	Methods of use of bovine respiratory syncytial virus recombinant dna, proteins, vaccines, antibodies and transformed cells
GB9200117D0 (en) *	1992-01-06	1992-02-26	Connaught Lab	Production of recombinant chimeric proteins for vaccine use
CA2136677A1 (en) *	1993-12-29	1995-06-30	Intervet, Inc.	Method of intranasally administering to bovines a trivalent vaccine containing modified live ibrv, pl3v and brsv
EP0740704A1 (en) *	1994-01-27	1996-11-06	University Of Massachusetts Medical Center	Immunization by inoculation of dna transcription unit
US5541102A (en) *	1994-09-02	1996-07-30	Board Of Regents, University Of Nebraska-Lincoln	Bovine cell line resistant to in vitro infection by bovine viral diarrhea virus and all other known pestiviruses
US6019980A (en)	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US6060457A (en)	1996-06-20	2000-05-09	Universite De Montreal	DNA plasmid vaccine for immunization of animals against BVDV
FR2751229B1 (fr) *	1996-07-19	1998-11-27	Rhone Merieux	Formule de vaccin polynucleotidique notamment contre la pathologie respiratoire des bovins
JP5566663B2 (ja) *	2009-11-09	2014-08-06	三菱重工業株式会社	多翼遠心ファンおよびそれを用いた空気調和機

1996
- 1996-07-19 FR FR9609403A patent/FR2751229B1/fr not_active Expired - Lifetime
1997
- 1997-07-06 NZ NZ517686A patent/NZ517686A/xx not_active IP Right Cessation
- 1997-07-06 NZ NZ508939A patent/NZ508939A/en not_active IP Right Cessation
- 1997-07-06 NZ NZ508940A patent/NZ508940A/xx not_active IP Right Cessation
- 1997-07-11 AR ARP970103111A patent/AR007862A1/es active IP Right Grant
- 1997-07-15 HR HR9609403A patent/HRP970383A2/hr not_active Application Discontinuation
- 1997-07-16 EP EP97934578A patent/EP0912194B1/fr not_active Expired - Lifetime
- 1997-07-16 UA UA99020960A patent/UA70914C2/uk unknown
- 1997-07-16 IL IL12770397A patent/IL127703A0/xx active IP Right Grant
- 1997-07-16 DE DE69725988T patent/DE69725988T2/de not_active Expired - Lifetime
- 1997-07-16 ES ES97934578T patent/ES2210548T3/es not_active Expired - Lifetime
- 1997-07-16 HU HU9902791A patent/HU225169B1/hu unknown
- 1997-07-16 MA MA24716A patent/MA24269A1/fr unknown
- 1997-07-16 AT AT97934578T patent/ATE253376T1/de active
- 1997-07-16 HU HU0500910A patent/HU228353B1/hu unknown
- 1997-07-16 DE DE69734483T patent/DE69734483T2/de not_active Expired - Lifetime
- 1997-07-16 WO PCT/FR1997/001325 patent/WO1998003200A2/fr not_active Ceased
- 1997-07-16 DK DK03016996T patent/DK1382348T3/da active
- 1997-07-16 EP EP03016996A patent/EP1382348B1/fr not_active Expired - Lifetime
- 1997-07-16 NZ NZ333751A patent/NZ333751A/en not_active IP Right Cessation
- 1997-07-16 JP JP09535655A patent/JP2000516200A/ja active Pending
- 1997-07-16 PT PT97934578T patent/PT912194E/pt unknown
- 1997-07-16 ES ES03016996T patent/ES2254833T3/es not_active Expired - Lifetime
- 1997-07-16 BR BR9710506A patent/BR9710506A/pt not_active Application Discontinuation
- 1997-07-16 PL PL97331236A patent/PL190122B1/pl unknown
- 1997-07-16 ZA ZA976283A patent/ZA976283B/xx unknown
- 1997-07-16 AU AU37735/97A patent/AU734442B2/en not_active Expired
- 1997-07-16 CZ CZ0017599A patent/CZ298898B6/cs not_active IP Right Cessation
- 1997-07-16 AT AT03016996T patent/ATE307607T1/de active
- 1997-07-16 CZ CZ20070776A patent/CZ298915B6/cs not_active IP Right Cessation
- 1997-07-16 DK DK97934578T patent/DK0912194T3/da active
- 1997-07-16 ID IDP972480A patent/ID19513A/id unknown
- 1997-07-16 CA CA2260855A patent/CA2260855C/en not_active Expired - Lifetime
- 1997-07-17 AP APAP/P/1997/001044A patent/AP9701044A0/en unknown
- 1997-07-18 CO CO97040983A patent/CO4700306A1/es unknown
1998
- 1998-01-16 PE PE1998000035A patent/PE84699A1/es not_active Application Discontinuation
- 1998-12-23 IL IL127703A patent/IL127703A/en not_active IP Right Cessation
1999
- 1999-01-15 US US09/232,279 patent/US6376473B1/en not_active Expired - Lifetime
2002
- 2002-02-28 US US10/085,519 patent/US6818628B2/en not_active Expired - Lifetime
- 2002-12-05 RU RU2002132831/13A patent/RU2305560C2/ru active

Also Published As

Publication number	Publication date
HUP9902791A2 (hu)	1999-12-28
DK1382348T3 (da)	2006-03-13
DE69725988T2 (de)	2004-11-11
RU2002132831A (ru)	2005-01-20
DK0912194T3 (da)	2004-03-15
AP9701044A0 (en)	1997-07-31
HU225169B1 (en)	2006-07-28
BR9710506A (pt)	1999-08-17
EP0912194A2 (fr)	1999-05-06
CA2260855C (en)	2012-01-03
RU2305560C2 (ru)	2007-09-10
EP1382348A2 (fr)	2004-01-21
ID19513A (id)	1998-07-16
FR2751229A1 (fr)	1998-01-23
NZ508940A (en)	2002-09-27
US6818628B2 (en)	2004-11-16
CZ17599A3 (cs)	1999-06-16
AU3773597A (en)	1998-02-10
HRP970383A2 (en)	1998-10-31
ATE253376T1 (de)	2003-11-15
NZ517686A (en)	2003-01-31
CZ298915B6 (cs)	2008-03-12
HU0500910D0 (en)	2005-11-28
DE69734483D1 (de)	2005-12-01
PL331236A1 (en)	1999-07-05
NZ508939A (en)	2002-04-26
WO1998003200A2 (fr)	1998-01-29
CA2260855A1 (en)	1998-01-29
DE69734483T2 (de)	2006-07-20
MA24269A1 (fr)	1998-04-01
EP1382348B1 (fr)	2005-10-26
PE84699A1 (es)	1999-11-28
ES2210548T3 (es)	2004-07-01
CO4700306A1 (es)	1998-12-29
ATE307607T1 (de)	2005-11-15
US20020160018A1 (en)	2002-10-31
DE69725988D1 (de)	2003-12-11
UA70914C2 (uk)	2004-11-15
PL190122B1 (pl)	2005-11-30
AR007862A1 (es)	1999-11-24
AU734442B2 (en)	2001-06-14
WO1998003200A3 (fr)	1998-02-26
HUP9902791A3 (en)	2000-03-28
CZ298898B6 (cs)	2008-03-05
US6376473B1 (en)	2002-04-23
EP1382348A3 (fr)	2004-01-28
EP0912194B1 (fr)	2003-11-05
ES2254833T3 (es)	2006-06-16
NZ333751A (en)	2001-03-30
IL127703A (en)	2006-12-31
FR2751229B1 (fr)	1998-11-27
JP2000516200A (ja)	2000-12-05
PT912194E (pt)	2004-03-31
ZA976283B (en)	1999-01-19
HU228353B1 (en)	2013-03-28

Publication	Publication Date	Title
IL127703A0 (en)	1999-10-28	Polynucleotide vaccine formula particularly for treating bovine respiratory disease
HUP9903822A3 (en)	2010-01-28	Polynucleotide vaccine formula for treating porcine respiratory and reproductive diseases
AU3699397A (en)	1998-02-10	Polynucleotide vaccine formula for treating dog diseases, particularly respiratory and digestive diseases
GB9501893D0 (en)	1995-03-22	Animal treatment apparatus
EP1043991A4 (en)	2005-02-02	TREATMENT OF ALZHEIMER DISEASE
EP0951293A4 (en)	2002-06-26	METHOD FOR TREATING ALZHEIMER DISEASE
HUP0103976A3 (en)	2008-04-28	Novel methods for therapeutic vaccination
PL331202A1 (en)	1999-07-05	Polynucleotidic vaccine composition for treating horses' diseases
HUP9902790A3 (en)	2000-03-28	Avian polynucleotide vaccine formula
ZA95556B (en)	1996-07-24	Combination treatment for osteoporosis
HU9701540D0 (en)	1997-10-28	Pharmaceutical composition for improving gastrointestinal blood circulation
HU910312D0 (en)	1991-08-28	Preparation for treating human nails
IL135584A0 (en)	2001-05-20	Method for treating alzheimer's disease
HUP0000954A3 (en)	2001-04-28	Medicinal compositions for treating cardiac diseases caused by cardiac hypertrophy
GB9410512D0 (en)	1994-07-13	Novel treatment
IL120000A0 (en)	1997-04-15	Apparatus for cardiac treatment
HUP9904173A3 (en)	2001-04-28	Pharmaceutical composition for treating viral diseases
GB9411635D0 (en)	1994-08-03	Novel treatment
HUT72054A (en)	1996-03-28	Agents for treating metabolic bone diseases
GB2290452B (en)	1997-10-01	Shoe treatment apparatus
PL320564A1 (en)	1997-10-13	Therapeutic set for treating osteoporosis
SI1117421T1 (en)	2004-12-31	Methods for therapeutic vaccination
GB9704174D0 (en)	1997-04-16	Agent for medical treatment
GB2354946B (en)	2001-05-16	Means for the treatment of prion disease
GB9411632D0 (en)	1994-08-03	Novel treatment

Legal Events

Date	Code	Title
2007-07-06	FF	Patent granted
2007-07-06	KB	Patent renewed
2007-09-20	KB	Patent renewed